• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因转换重组和多发性骨髓瘤风险与生存相关的基因遗传多态性:IMMEnSE 研究。

Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study.

机构信息

a Department of Biology , University of Pisa , Pisa , Italy.

b Genomic Epidemiology Group, German Cancer Research Center (DKFZ) , Heidelberg , Germany.

出版信息

Leuk Lymphoma. 2019 Jul;60(7):1803-1811. doi: 10.1080/10428194.2018.1551536. Epub 2019 Jan 11.

DOI:10.1080/10428194.2018.1551536
PMID:30633655
Abstract

Genetic variants in genes acting during the maturation process of immature B-cell to differentiated plasma cell could influence the risk of developing multiple myeloma (MM). During B-cell maturation, several programmed genetic rearrangements occur to increase the variation of the immunoglobulin chains. Class switch recombination (CSR) is one of the most important among these mechanisms. Germline polymorphisms altering even subtly this process could play a role in the etiology and outcome of MM. We performed an association study of 30 genetic variants in the key CSR genes, using 2632 MM patients and 2848 controls from the International Multiple Myeloma rESEarch (IMMEnSE) consortium, the Heidelberg MM Group and the ESTHER cohort. We found an association between -rs1555902 and decreased MM risk, which approached statistical significance, as well as significant associations between rs3794318 and better outcome. Our results add to our knowledge on the genetic component of MM risk and survival.

摘要

在未成熟 B 细胞向分化浆细胞成熟过程中起作用的基因中的遗传变异可能会影响多发性骨髓瘤(MM)的发病风险。在 B 细胞成熟过程中,会发生几种程序性遗传重排,以增加免疫球蛋白链的变异。类别转换重组(CSR)是这些机制中最重要的机制之一。即使这种过程发生细微改变的种系多态性也可能在 MM 的病因和结局中发挥作用。我们使用来自国际多发性骨髓瘤 rESEarch(IMMEnSE)联盟、海德堡 MM 小组和 ESTHER 队列的 2632 名 MM 患者和 2848 名对照,对关键 CSR 基因中的 30 个遗传变异进行了关联研究。我们发现 -rs1555902 与 MM 风险降低之间存在关联,接近统计学意义,并且 rs3794318 与更好的预后之间存在显著关联。我们的结果增加了我们对 MM 风险和生存的遗传成分的认识。

相似文献

1
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study.基因转换重组和多发性骨髓瘤风险与生存相关的基因遗传多态性:IMMEnSE 研究。
Leuk Lymphoma. 2019 Jul;60(7):1803-1811. doi: 10.1080/10428194.2018.1551536. Epub 2019 Jan 11.
2
Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination.非同源末端连接DNA连接酶IV的基因变异可能会影响多发性骨髓瘤的发病风险,多发性骨髓瘤是一种以异常类别转换重组为特征的肿瘤。
J Med Genet. 2002 Dec;39(12):900-5. doi: 10.1136/jmg.39.12.900.
3
EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching.EB病毒编码的潜伏膜蛋白1与B细胞活化因子/ B淋巴细胞刺激因子(BAFF/BLyS)及增殖诱导配体(APRIL)协同作用,以诱导不依赖T细胞的Ig重链类别转换。
J Immunol. 2003 Nov 15;171(10):5215-24. doi: 10.4049/jimmunol.171.10.5215.
4
Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.组蛋白去乙酰化酶抑制剂上调B细胞微小RNA,这些微小RNA可使激活诱导的胞嘧啶脱氨酶(AID)和B淋巴细胞诱导成熟蛋白-1(Blimp-1)的表达沉默,从而对抗体和自身抗体反应进行表观遗传调控。
J Immunol. 2014 Dec 15;193(12):5933-50. doi: 10.4049/jimmunol.1401702. Epub 2014 Nov 12.
5
The block in immunoglobulin class switch recombination caused by activation-induced cytidine deaminase deficiency occurs prior to the generation of DNA double strand breaks in switch mu region.由激活诱导的胞苷脱氨酶缺陷导致的免疫球蛋白类别转换重组障碍发生在转换μ区域DNA双链断裂产生之前。
J Immunol. 2003 Sep 1;171(5):2504-9. doi: 10.4049/jimmunol.171.5.2504.
6
Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.同种型转换的滤泡性淋巴瘤在激活诱导的胞苷脱氨酶表达与体细胞超突变之间表现出解离。
Leuk Lymphoma. 2016;57(1):151-60. doi: 10.3109/10428194.2015.1037758. Epub 2015 May 18.
7
BATF regulates the expression of Nfil3, Wnt10a and miR155hg for efficient induction of antibody class switch recombination in mice.BATF 调节 Nfil3、Wnt10a 和 miR155hg 的表达,以有效诱导小鼠抗体类别转换重组。
Eur J Immunol. 2018 Sep;48(9):1492-1505. doi: 10.1002/eji.201747360. Epub 2018 Jun 26.
8
The DNA Ligase IV Syndrome R278H Mutation Impairs B Lymphopoiesis via Error-Prone Nonhomologous End-Joining.DNA连接酶IV综合征的R278H突变通过易出错的非同源末端连接损害B淋巴细胞生成。
J Immunol. 2016 Jan 1;196(1):244-55. doi: 10.4049/jimmunol.1403099. Epub 2015 Nov 25.
9
Two new isotype-specific switching activities detected for Ig class switching.在Ig类别转换中检测到两种新的同型特异性转换活性。
J Immunol. 2002 Mar 15;168(6):2835-46. doi: 10.4049/jimmunol.168.6.2835.
10
Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium.外源性物质转运蛋白ABCB1、ABCG2、ABCC2、ABCC1、ABCC3的多态性与多发性骨髓瘤风险:国际多发性骨髓瘤研究(IMMEnSE)联盟背景下的一项病例对照研究
Leukemia. 2012 Jun;26(6):1419-22. doi: 10.1038/leu.2011.352. Epub 2011 Dec 20.

引用本文的文献

1
Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study.液体活检衍生的DNA来源作为多发性骨髓瘤综合突变分析的工具:一项比较研究
Cancers (Basel). 2022 Oct 7;14(19):4901. doi: 10.3390/cancers14194901.
2
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.DNAJB4 中的多效变异与多发性骨髓瘤风险相关。
Int J Cancer. 2023 Jan 15;152(2):239-248. doi: 10.1002/ijc.34278. Epub 2022 Oct 1.
3
The Role of DNA Repair in Genomic Instability of Multiple Myeloma.
DNA 修复在多发性骨髓瘤基因组不稳定性中的作用。
Int J Mol Sci. 2022 May 19;23(10):5688. doi: 10.3390/ijms23105688.
4
Genetic Analysis of Acid β-Glucosidase in Patients with Multiple Myeloma from Central Taiwan: A Small-Cohort Case-Control Study.台湾中部多发性骨髓瘤患者酸性β-葡萄糖苷酶的基因分析:一项小队列病例对照研究。
Biomed Hub. 2021 Nov 29;6(3):138-144. doi: 10.1159/000519704. eCollection 2021 Sep-Dec.
5
Genome Instability in Multiple Myeloma: Facts and Factors.多发性骨髓瘤中的基因组不稳定:事实与因素
Cancers (Basel). 2021 Nov 26;13(23):5949. doi: 10.3390/cancers13235949.
6
Genetically determined telomere length and multiple myeloma risk and outcome.遗传决定的端粒长度与多发性骨髓瘤风险和预后。
Blood Cancer J. 2021 Apr 14;11(4):74. doi: 10.1038/s41408-021-00462-y.
7
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients.基因表达数量性状基因座与多发性骨髓瘤患者生存相关的预测预后。
Int J Cancer. 2021 Jul 15;149(2):327-336. doi: 10.1002/ijc.33547. Epub 2021 Mar 30.
8
Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia.被诊断患有惰性淋巴样恶性肿瘤(包括慢性淋巴细胞白血病)的一级亲属之间的生存一致性。
Eur J Haematol. 2020 Dec;105(6):779-785. doi: 10.1111/ejh.13510. Epub 2020 Sep 29.
9
Treatment evolution and improved survival in multiple myeloma in Taiwan.台湾多发性骨髓瘤的治疗演变和生存改善。
Ann Hematol. 2020 Feb;99(2):321-330. doi: 10.1007/s00277-019-03858-w. Epub 2019 Dec 5.
10
Germline Risk Contribution to Genomic Instability in Multiple Myeloma.种系风险对多发性骨髓瘤基因组不稳定性的影响
Front Genet. 2019 May 8;10:424. doi: 10.3389/fgene.2019.00424. eCollection 2019.